BURZYNSKI RESEARCH INSTITUTE INC
BURZYNSKI RESEARCH INSTITUTE INC
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | 2023-02-28 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense Current | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | |||||
Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 130 | 130 | 130 | 129 | 129 | 129 | 128 | 128 | 128 | 127 | 127 | 127 | |||||
Retained Earnings Accumulated Deficit | -130 | -130 | -130 | -129 | -129 | -129 | -128 | -128 | -128 | -127 | -127 | -127 | |||||
Stockholders Equity | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | |||||
Common Stock Shares Issued | 131 | 131 | 131 | 131 | 131 | 131 | 131 | 131 | 131 | 131 | 131 | 131 | |||||
Shares Outstanding | 131 | 131 | 131 | 131 | 131 | 131 | 131 | 131 | 131 | 131 | 131 | 131 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 41.18% | -23.53% | 14.71% | 8.57% | 20.00% | -42.86% | -10.53% | -34.21% | -34.21% | - | - | - |
| 2025 | -19.51% | 0.00% | 70.73% | 0.00% | -2.78% | 38.89% | 2.50% | 45.00% | 22.50% | 57.14% | 28.57% | 37.14% |
| 2024 | 0.00% | -43.53% | -51.76% | -6.25% | 0.00% | -8.33% | -28.57% | -33.33% | -42.86% | -30.23% | -4.65% | -23.26% |
| 2023 | - | - | - | - | - | - | - | - | - | 7.69% | 30.77% | 3.08% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
BURZYNSKI RESEARCH INSTITUTE INC (BZYR) — SEC Financial Statements & Analysis
BURZYNSKI RESEARCH INSTITUTE INC (BZYR) is a in vitro & in vivo diagnostic substances company, incorporated in DE. BURZYNSKI RESEARCH INSTITUTE INC trades on OTC as: BZYR. Based on its latest SEC filing (Form 10-Q, period ending 2025-11-30), BURZYNSKI RESEARCH INSTITUTE INC reported a Price-to-Book (P/B) ratio of -85.88x (TTM), at a market cap of $5.78M. Figures below are sourced from SEC EDGAR, as-filed.
- P/B TTM
- -85.88x
- Market Cap
- $5.78M
Data as of 2025-11-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BURZYNSKI RESEARCH INSTITUTE INC in?
BURZYNSKI RESEARCH INSTITUTE INC (BZYR) operates in the In Vitro & In Vivo Diagnostic Substances industry.
What is BZYR's market cap?
BURZYNSKI RESEARCH INSTITUTE INC (BZYR) has a market capitalization of $5.78M as of 2025-11-30.
What exchange does BZYR trade on?
BURZYNSKI RESEARCH INSTITUTE INC (BZYR) trades on the OTC.
Where is BURZYNSKI RESEARCH INSTITUTE INC incorporated?
BURZYNSKI RESEARCH INSTITUTE INC is incorporated in DE.